These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 28749005)

  • 1. Screening of furanocoumarin derivatives as cytochrome P450 3A4 inhibitors in citrus.
    Masuda M; Watanabe S; Tanaka M; Tanaka A; Araki H
    J Clin Pharm Ther; 2018 Feb; 43(1):15-20. PubMed ID: 28749005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of furanocoumarin derivatives in citrus fruits by enzyme-linked immunosorbent assay.
    Saita T; Fujito H; Mori M
    Biol Pharm Bull; 2004 Jul; 27(7):974-7. PubMed ID: 15256725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of furanocoumarins in Advantra Z® (Citrus aurantium, bitter orange) extracts.
    Stohs SJ; Miller H; Romano F
    J Diet Suppl; 2014 Sep; 11(3):288-93. PubMed ID: 25026202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
    Bailey DG; Dresser GK; Bend JR
    Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins.
    Girennavar B; Jayaprakasha GK; Patil BS
    J Food Sci; 2007 Oct; 72(8):C417-21. PubMed ID: 17995595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.
    Kakar SM; Paine MF; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labeled content of two furanocoumarins in dietary supplements correlates with neither actual content nor CYP3A inhibitory activity.
    VanderMolen KM; Ainslie GR; Paine MF; Oberlies NH
    J Pharm Biomed Anal; 2014 Sep; 98():260-5. PubMed ID: 24951959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Furanocoumarins contents and cytochrome P450 3A (CYP3A) inhibitory activities of various processed fruit peel products: outflow of 6',7'-Dihydroxybergamottin during processing treatment of peel].
    Ishihara M; Toda H; Sunagane N; Ohta T
    Yakugaku Zasshi; 2011; 131(5):679-84. PubMed ID: 21532264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing grapefruit juice with γ-cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity.
    Yamasaki K; Iohara D; Oyama Y; Nishizaki N; Kawazu S; Nishi K; Kadowaki D; Taguchi K; Otagiri M; Seo H
    J Pharm Pharmacol; 2020 Mar; 72(3):356-363. PubMed ID: 31828807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a comprehensive analytical method for furanocoumarins in grapefruit and their metabolites in plasma and urine using UPLC-MS/MS: a preliminary study.
    Lee SG; Kim K; Vance TM; Perkins C; Provatas A; Wu S; Qureshi A; Cho E; Chun OK
    Int J Food Sci Nutr; 2016 Dec; 67(8):881-7. PubMed ID: 27396405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine.
    Paine MF; Widmer WW; Pusek SN; Beavers KL; Criss AB; Snyder J; Watkins PB
    Am J Clin Nutr; 2008 Apr; 87(4):863-71. PubMed ID: 18400708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contents of furanocoumarins in grapefruit juice and health foods].
    Sakamaki N; Nakazato M; Matsumoto H; Hagino K; Hirata K; Ushiyama H
    Shokuhin Eiseigaku Zasshi; 2008 Aug; 49(4):326-31. PubMed ID: 18787320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major furocoumarins in grapefruit juice II: phototoxicity, photogenotoxicity, and inhibitory potency vs. cytochrome P450 3A4 activity.
    Messer A; Raquet N; Lohr C; Schrenk D
    Food Chem Toxicol; 2012 Mar; 50(3-4):756-60. PubMed ID: 22155270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different roles of pummelo furanocoumarin and cytochrome P450 3A5*3 polymorphism in the fate and action of felodipine.
    Guo LQ; Chen QY; Wang X; Liu YX; Chu XM; Cao XM; Li JH; Yamazoe Y
    Curr Drug Metab; 2007 Aug; 8(6):623-30. PubMed ID: 17691921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction.
    Paine MF; Widmer WW; Hart HL; Pusek SN; Beavers KL; Criss AB; Brown SS; Thomas BF; Watkins PB
    Am J Clin Nutr; 2006 May; 83(5):1097-105. PubMed ID: 16685052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New grapefruit cultivars exhibit low cytochrome P4503A4-Inhibition activity.
    Guttman Y; Yedidia I; Nudel A; Zhmykhova Y; Kerem Z; Carmi N
    Food Chem Toxicol; 2020 Mar; 137():111135. PubMed ID: 31968226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition.
    Paine MF; Criss AB; Watkins PB
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1151-60. PubMed ID: 15485894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of maturity, processing, and storage on the furanocoumarin composition of grapefruit and grapefruit juice.
    Cancalon PF; Barros SM; Haun C; Widmer WW
    J Food Sci; 2011 May; 76(4):C543-8. PubMed ID: 22417333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White and colored grapefruit juice produce similar pharmacokinetic interactions.
    Uesawa Y; Abe M; Mohri K
    Pharmazie; 2008 Aug; 63(8):598-600. PubMed ID: 18771009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peel.
    Wangensteen H; Molden E; Christensen H; Malterud KE
    Eur J Clin Pharmacol; 2003 Feb; 58(10):663-8. PubMed ID: 12610742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.